DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
批准号:
6634581
负责人:
PAUL J EZZO
金额:
$11.88万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2006-02-28
关键词:
Actinobacillus actinomycetemcomitans apoptosis bacteria infection mechanism bacterial toxins biopsy clinical research confocal scanning microscopy dendritic cells dental disorder chemotherapy dental disorder diagnosis enzyme linked immunosorbent assay gingiva helper T lymphocyte human subject human therapy evaluation immunofluorescence technique immunoregulation mixed tissue /cell culture monoclonal antibody morphometry patient oriented research periodontitis phenotype polymerase chain reaction stainings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Dr. Ezzo's long-term goal is to establish a successful career in
academic dentistry. His immediate career goal is to further his development as
an independent researcher in the area of clinically-oriented periodontal
research. The research environment established at Baylor College of Dentistry
(BCD) by Dr. Christopher Cutler, in collaboration with Dr. Jacques Banchereau
at the Baylor Institute for Immunological Research (BIIR), will enable Dr. Ezzo
to pursue his career development in a unique scientific/clinical niche.
Furthermore, Dr. Martha Nunn, a biostatistician with expertise in designing and
analyzing clinical trials, will co-mentor Dr. Ezzo. Dr. Cutler has established
a collaboration with Dr. J. Banchereau as a result of common interests
including: 1) identification and characterization of different dendritic cell
(DC) subsets in human tissues, 2) impact of DCs on infectious disease, and 3)
ability of DCs to induce protective immunity against infection. At BCD and
BIIR, greater than 80 percent of Dr. Ezzo's time will be appropriated for the
development of a research career. A systematic plan including courses in
clinical research has been developed in order to broaden the knowledge Dr. Ezzo
received in his Dentist/Scientist Award training. Both the didactic and
research phases of the career plan will allow Dr. Ezzo to expand his experience
in clinical research and to achieve his career goals. Characterizing the
interaction between the DC and A. actinomycetemcomitans (Aa) is a logical "next
step" in the process of career building for Dr. Ezzo. Dr. Ezzo's scientific
background involves characterizing the T cell response to Aa and will be
helpful in elucidating the importance of the DC in the immune response to this
periodontal pathogen. DCs have been referred to as "nature's adjuvant" due to
their ability to efficiently prime naive T cells. Their work has established
that the periodontium is a significant repository of DC subsets. Their role in
the immune response to periodontal pathogens, like Aa, is presently unknown.
Distinct DC subsets, derived from myeloid and lymphoid precursors, are capable
of providing different cytokine microenvironments that promote either Th1 or
Th2 T cell development. The DC subset elicited during an infection with Aa,
therefore, may have a profound effect on the outcome of infection. The
hypothesis is that the predominant DC subset elicited in LJP lesions is
differentially susceptible to Aa and its leukotoxin (lkt). Lkt preferentially
targets myeloid cell derived-DCs that bear sensitivity to its effects. These
subsets are eliminated, contributing to a pronounced Th1 bias. An inflammatory
response ensues resulting in the inappropriate destruction of periodontal
tissues. This hypothesis will be addressed by the following aims: 1) to
characterize in situ the DC subsets found in gingiva from UP patients before
and after clinical treatment, 2) to isolate and characterize DCs from UP
patients, and 3) to perform in vitro studies of DC phenotype and function after
co-culture with lkt+lkt-Aa.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
-
批准号:6516355
-
项目类别:
-
资助金额:$11.59万
-
财政年份:2001
-
负责人:PAUL J EZZO
-
依托单位:
DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
-
批准号:6721202
-
项目类别:
-
资助金额:$12.14万
-
财政年份:2001
-
负责人:PAUL J EZZO
-
依托单位:
DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
-
批准号:6228863
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2001
-
负责人:PAUL J EZZO
-
依托单位:
T CELL RESPONSE TO AA IN MICE
-
批准号:6104530
-
项目类别:
-
资助金额:$1.14万
-
财政年份:1998
-
负责人:PAUL J EZZO
-
依托单位:
T CELL RESPONSE TO AA IN MICE
-
批准号:6238295
-
项目类别:
-
资助金额:$3.97万
-
财政年份:1997
-
负责人:PAUL J EZZO
-
依托单位:
PERIODONTICS AND MICROBIOLOGY
-
批准号:3775548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL J EZZO
-
依托单位:
T CELL RESPONSE TO AA IN MICE
-
批准号:5210010
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL J EZZO
-
依托单位:--
T CELL RESPONSE TO AA IN MICE IMMUNIZED SUBCUTANEOUSLY OR ORALLY INFECTED
-
批准号:3732387
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL J EZZO
-
依托单位:
PERIODONTICS AND MICROBIOLOGY
-
批准号:3753431
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL J EZZO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: